Delivery Order 70FB7020D00000024-70FB7020F00000100

Award Date 5/6/20
Potential Completion Date 7/5/20
Potential Value $3.7M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA 95605, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $79,875 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to small business Gemini Bioproducts LLC. The contract is to provide cell culture media, sera, and other reagents in support of biomedical research and emergency response efforts. Gemini Bioproducts is a manufacturer and supplier of these products to the scientific community. This contract is set aside for small businesses. Gemini Bioproducts also...
This $3,501.23 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The contract is to provide fetal bovine serum, viral...
Greiner Bio-One North America, Inc. was awarded a $2.32 million delivery order against the Department of Homeland Security Federal Emergency Management Agency's multiple-award contract vehicle for "Swabs and Media in Support of COVID-19 Response." The delivery order calls for viral stabilization tubes to support the agency's coronavirus response efforts. Performance will take place in Fairdale, Kentucky over a two-month period concluding in early July. Funding is provided by FEMA's...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $14,745.00 award is for in vitro diagnostic substances, reagents, test kits, and sets. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community across academic research, biotechnology, cell and gene therapy, and...
This $331,482.36 firm-fixed-price purchase order was awarded by the Federal Emergency Management Agency (FEMA) Incident Support Section to Greiner Bio-One North America, Inc., a for-profit manufacturer of goods, to provide virus transport medium (testing supplies) in support of the Coronavirus COVID-19 response. The contract has a completion date of May 15, 2020 and did not utilize a small business set-aside. Greiner Bio-One North America, Inc. is a global partner for biotechnology, medical...
This is a Blanket Purchase Agreement (BPA) call awarded to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The $27,000 contract is for a firm fixed price order for the delivery of unspecified products, likely related to the company's past awards to provide fetal bovine serum, viral transport media, and saline tubes in support of biomedical...
Technimark LLC was awarded a $178,001 firm fixed price delivery order against the Swabs and Media in Support of COVID-19 Response multiple-award ID/IQ contract to provide testing supplies including swabs and media. The Federal Emergency Management Agency Incident Support Section within the Department of Homeland Security is the funding agency for this order placed in support of the national COVID-19 response. Performance will take place in Asheboro, North Carolina over a six-month period...
This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...
This federal contract award was made by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The $11,739 firm-fixed price contract is a Blanket Purchase Agreement (BPA) call that provides Gemini's products in support of biomedical research and emergency response efforts. Gemini has received prior sole-source awards from the National Institutes of...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $6,165.00 firm fixed-price purchase order is for the delivery of 500 ml bottles of fetal bovine serum, a critical cell culture reagent used in biomedical research and pharmaceutical development. The contract has no set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture...

Gemini Bioproducts LLC was awarded a $3.7 million firm fixed price delivery order against the Swabs and Media in Support of COVID-19 Response master IDIQ contract by the Federal Emergency Management Agency Incident Support Section. The delivery order is for the provision of 300,000 saline tubes and 455,000 viral transport media to support COVID-19 testing efforts, with performance through July 2020. Funding is provided by FEMA in support of the agency's coronavirus response mission. No subcontractors or set aside designations were indicated.

Generated 12/25/23, 12:16 AM